Risk factors and treatment of suicidality in borderline personality disorder

Clinical Neuroscience Research

Volumn 1, Issue 5, 2001, Pages 351-361

  Stanley, Barbara ^a,b   Brodsky, Beth ^a,b  

^a College of Physicians and Surgeons ^*  (United States)

^b NEW YORK STATE PSYCHIATRIC INSTITUTE   (United States)

Author keywords

Borderline personality disorder; Psychotherapy; Risk factors; Suicidal behavior

Indexed keywords

EID: 0345878313     PISSN: 15662772     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1566-2772(01)00037-8     Document Type: Review

References (115)

1. Frances A, Fyer M, Clarkin J. Personality and suicide. In: Mann JJ, Stanley M, editors. Psychobiology of suicidal behavior, NY: New York Academy of Sciences, 1986.
2. Stone M, Hurt S, Stone D. The PI500: long-term follow-up of borderline inpatients meeting DSM-III criteria I. Global outcome. J Pers Disord 1987;1:291-298.
3. Guze SB, Robins E. Suicide and primary affective disorders. Br J Psychiatry 1970;117(539):437-438.
4. Winokur G, Tsuang M. The Iowa 500: suicide in mania, depression, and schizophrenia. Am J Psychiatry 1975;132(6):650-651.
5. McGlashan TH. The Chestnut Lodge follow-up study: III. Long-term outcome of borderline personalities. Arch Gen Psychiatry 1986;43:20-30.
6. Mann JJ, Waternaux C, Haas GL, Malone KM. Toward a model of suicidal behavior in psychiatric patients. Am J Psychiatry 1999;156(2):181-189.
7. Gunderson D. Borderline personality disorder. Washington DC: American Psychiatric Press, 1984.
8. Fyer MR. Suicide attempts in patients with borderline personality disorder. Am J Psychiatry 1988;145:737-739.
9. Pascolo-Fabrici E, DeMarie F, de Vanna M, Aguglia E. Borderline disorders and the risk of suicide. New Trends Exp Clin Psychiatry 1998;14(3):151-156.
10. Robins E. The final months. New York: Oxford University Press, 1981.
11. Barraclough B, Bunch J, Nelson B, Sainsbury P. A hundred cases of suicide: clinical aspects. Br J Psychiatry 1974;125:355-373.
12. Dorpat TL, Ripley HS. The relationship between attempted suicide and committed suicide. Compr Psychiatry 1967;8(2):74-79.
13. Shearer SL, Peter CP, Quaytman MS, Wadman BE. Intent and lethality of suicide attempts among female borderline inpatients. Am J Psychiatry 1988;145:1424-1427.
14. Soloff PH, Lis JA, Kelly T, Cornelius J, Ulrich R. Risk factors for suicidal behavior in borderline personality disorder. Am J Psychiatry 1994;151(9):1316-1323.
15. Roy A. Self-mutilation. Br J Med Psychology 1978;51:201-20313.
16. Rosenthal RJ, Rinzler C, Walsh R, Klausner E. Wrist-cutting syndrome: the meaning of a gesture. Am J Psychiatry 1972;128: 1363-1368.
17. Favazza AR, Conterio K. Female habitual self-mutilators. Acta Psychiatr Scand 1989;79(3):283-289.
18. Stanley B, Winchel R, Molcho A, Simeon D, Stanley M. Suicide and the self-harm continuum: phenomenological and biochemical evidence. Int Rev Psychiatry 1992;4:149-155.
19. Simeon D, Stanley B, Frances A, Mann JJ, Winchel R, Stanley M. Self-mutilation: psychological and biological correlates. Am J Psychiatry 1992;149:221-226.
20. Stanley Winchel RM, Stanley M. Self-injurious behavior: a review of the behavior and biology of self-mutilation. Am J Psychiatry 1991;148(3):306-317.
21. Corbitt EM, Malone KM, Haas GL, Mann JJ. Suicidal behavior in patients with major depression and comorbid personality disorders. J Affect Disord 1996;39:61-72.
22. Kessler RC, Walters EE. Epidemiology of DSM-III-R major depression and minor depression among adolescents and young adults in the National Comorbidity Survey. Depress Anxiety 1998;7(1):3-14.
23. Radomsky ED, Haas GL, Mann JJ, Sweeney JA. Suicidal behavior in patients with schizophrenia and other psychotic disorders. Am J Psychiatry 1999;156(10):1590-1595.
24. Isometsa ET, Henriksson MM, Heikkinen ME, et al. Suicide among subjects with personality disorders. Am J Psychiatry 1996;153:5.
25. Kullgren G. Factors associated with completed suicide in borderline personality disorder. J Nervous Mental Dis 1988;176:40-44.
26. Dulit RA, Fyer MR, Leon AC, Brodsky BS, Frances AJ. Clinical correlates of self-mutilation in borderline personality disorder. Am J Psychiatry 1994;151(9):1305-1311.
27. Brodsky BS, Cloitre M, Dulit RA. Relationship of dissociation to self-mutilation and childhood abuse in borderline personality disorder. Am J Psychiatry 1995;152(12):1788-1792.
28. Ballinger BR. Minor self-injury. Br J Psychiatry 1971;118(546): 535-538.
29. Pao PN. The syndrome of delicate self-cutting. Br J Med Psychol 1969;42(3):195-206.
30. Stanley B, Gameroff M, Michalsen V, Mann JJ. Suicide attempters who self-mutilate: are they a unique population? Am J Psychiatry 2001;158(3):427-432.
31. Kjelsberg E, Eikeseth PH, Dahl AA. Suicide in borderline patients - predictive factors. Acta Psychiatr Scand 1991;84:283-287.
32. Paris J, Nowlis D, Brown R. Predictors of suicide in borderline personality disorder. Can J Psychiatry 1989;24:8-9.
33. Brodsky B, Malone K, Ellis S, Dulit R, Mann JJ. Characteristics of borderline personality disorder associated with suicidal behavior. Am J Psychiatry 1997;154:1715-1719.
34. Paris J. Completed suicide in borderline personality disorder. Psychiatr Ann 1990;20(1):19-21.
35. Mehlum L, Friis S, Vaglum P, Karterud S. The longitudinal pattern of suicidal behavior in borderline personality disorder: a prospective follow-up study. Acta Psychiatr Scand 1994;90:124-130.
36. Coccaro EF, Siever LJ, Klar HM, et al. Serotonergic studies in patients with affective and personality disorders: correlates with suicidal and impulsive aggressive behavior. Arch Gen Psychiatr 1989;46(7):587-599.
37. Brown GL, Goodwin FK. Cerebrospinal fluid correlates of suicide attempts and aggression. In: Mann JJ, Stanley M, editors. Psychobiology of suicidal behavior. New York: New York Academy of Sciences, 1986.
38. Gardner DL, Lucas PB, Cowdry RW. CSF metabolites in borderline personality disorder compared with normal controls. Biol Psychiatry 1990;28:247-254.
39. Coccaro EF, Silverman JM, Klar HM, Horvath TB, Siever LJ. Familial correlates of reduced central serotonergic system function in patients with personality disorders. Arch Gen Psychiatry 1994;51:318-324.
40. Verkes RJ, Van der Mast RC, Kerkhof AJ, et al. Platelet serotonin, monoamine oxidase activity, and [3H] paroxetine binding related to impulsive suicide attempts and borderline personality disorder. Biol Psychiatry 1998;43(10):740-746.
41. Brodsky BS, Oquendo MA, Ellis SP, Haas GL, Malone KM, Mann JJ. The relationship of childhood abuse to impulsivity and suicidal behavior in adults with major depression. Am J Psychiatry 2001 (in press).
42. Bremner JD, Licinio J, Darnell A, et al. Elavated CSF corticotropin-releasing factor concentrations in posttraumatic stress disorder. Am J Psychiatry 1997;154(5):624-629.
43. Yehuda R, Boisoneau D, Lowry MT, Giller EL. Dose-response changes inplasma cortisol and lymphocyte glucocorticoid receptors following dexamethasone administration in combat veterans with and without posttraumatic stress disorder. Arch Gen Psychiatry 1995;52:583-593.
44. Francis D, Caldji C, Champagne F, Plotsky P, Meaney M. The role of corticotropin-releasing factor-norepinephrine systems in mediating the effects of early experience on the development of behavioral and endocrine responses to stress. Biol Psychiatry 1999;46:1153-1166.
45. Koob G. Corticotropin-releasing factor, norepinephrine, and stress. Biol Psychiatry 1999;46:1167-1180.
46. Plotsky PM, Meaney MJ. Early, postnatal experience alters hypothalamic corticotropin-releasing factor (CRF) mRNA, median eminence CRF content and stress-induced release in adult rats. Mol Brain Res 1993;18:195-200.
47. van der Kolk BA, Perry JC, Herman JL. Childhood origins of self-destructive behavior. Am J Psychiatry 1991;148:1665-1671.
48. Boudewyn AC, Liem JH. Childhood sexual abuse as a precursor to depression and self-destructive behavior in adulthood. J Traum Stress 1995;8(3):445-459.
49. Brown GR, Anderson B. Psychiatric morbidity in adult inpatients with childhood histories of sexual and physical abuse. Am J Psychiatry 1991;148:55-61.
50. Ogata SN, Kilk KR, Gooodrich S, Lohr NE, Westen D, Hill EM. Childhood sexual and physical abuse in adult patients with borderline personality disorder. Am J Psychiatry 1990;147:1008-1013.
51. Herman JL, Perry JC, van der Kolk BA. Childhood trauma in borderline personality disorder. Am J Psychiatry 1989;146:490-495.
52. Brown GR, Anderson B. Psychiatric morbidity in adult inpatients with childhood histories of sexual and physical abuse. Am J Psychiatry 1991;148(1):55-61.
53. Malone KM, Haas GL, Sweeney JA, Mann JJ. Major depression and the risk of attempted suicide. J Affect Disord 1995;34:173-185.
54. Bronisch T, Hecht H. Comparison of depressed patients with and without suicide attempts in their past history. Acta Psychiatr Scand 1987(76):438-449.
55. Bron B, Strack M, Rudolph G. Childhood experiences of loss and suicide attempts: significance in depressive states of major depressed and dysthymic or adjustment disordered patients. J Affect Disord 1991;23:165-172.
56. Gould MS, Shaffer D, Fisher P, Garfinkel R. Separation/divorce and child and adolescent completed suicide. J Am Acad Child Adolesc Psychiatry 1998;37(2):155-162.
57. Roy A. Family history of suicide. Arch Gen Psychiatry 1983;40(9): 971-974.
58. Tsuang M. The risk of suicide in relatives of schizophrenics, manics, depressives and controls. J Clin Psychiatr 1983;44:396-400.
59. Black DW, Bell S, Hulbert J, Nasrallah A. The importance of Axis II in patients with major depression. A controlled study. Affect Disord 1988;14(2):115-122.
60. Loranger AW, Tulis EH. Family history of alcoholism in borderline personality disorder. Arch Gen Psychiatry 1985;42(2):153-157.
61. Winokur G, Coryell W. Familial subtypes of unipolar depression: a prospective study of familial pure depressive disease compared to depression spectrum disease. Biol Psychiatry 1992;32(11):1012-1018.
62. Silverman JM, Pinkham L, Horvath TB, et al. Affective and impulsive personality disorder traits in the relatives of patients with borderline personality disorder. Am J Psychiatry 1991;148(10): 1378-1385.
63. Friedman RC, Aronoff MS, Clarkin JF, Corn R, Hurt SW. History of suicidal behavior in depressed borderline patients. Am J Psychiatry 1983;140:1023-1026.
64. Joffe RT, Regan JJ. Personality and suicidal behavior in depressed patients. Compr Psychiatry 1989;30(2):157-160.
65. Links PS, Heslegrave RJ, Mitton JE, van Reekum R, Patrick J. Borderline personality disorder and substance abuse: consequences of comorbidity. Can J Psychiatry 1995;40(1):9-14.
66. Nace EP, Saxon Jr JJ, Shore N. A comparison of borderline and non-borderline alcoholic patients. Arch Gen Psychiatry 1983;40(1):54-56.
67. Rich CL, Runeson BS. Similarities in diagnostic comorbidity between suicide among young people in Sweden and the United States. Acta Psychiatr Scand 1992;86(5):335-339.
68. Runeson B, Beskow J. Borderline personality disorder in young Swedish suicides. J Nerv Ment Dis 1991;179(3):153-156.
69. Heikkinen ME, Henriksson MM, Isometsa ET, Marttunen MJ, Aro HM, Lonnqvist JK. Recent life events and suicide in personality disorders. J Nerv Ment Dis 1997;185(6):373-381.
70. Duberstein PR, Conwell Y, Cox C. Suicide in widowed persons. A psychological autopsy comparison of recently and remotely bereaved older subjects. Am J Geriatr Psychiatry 1998;6(4):328-334.
71. Linehan MM, Armstrong HE, Suarez A, Allmon DS, Heard H. Cognitive-behavioral treatment of chronically parasuicidal borderline patients. Arch Gen Psychiatry 1991;48:1060-1064.
72. Linehan MM, Heard HL, Armstrong HE. Naturalistic follow-up of a behavioral treatment for chronically parasuicidal borderline patients. Arch Gen Psychiatry 1993;50:971-975.
73. Shearin EN, Linehan MM. Patient-therapist ratings and relationship to progress in dialectical behavior therapy for borderline personality disorder. Behav Ther 1992;23:730-741.
74. Linehan MM, Tutek DA, Heard HL, Armstrong HE. Interpersonal outcome of cognitive-behavioral treatment for chronically suicidal borderline patients. Am J Psychiatry 1994;151:1771-1776.
75. Shearin EN, Linehan MM. Dialectical behavior therapy for borderline personality disorder: theoretical and empirical foundations. Acta Psychiatr Scand 1994;89:61-68.
76. Springer T, Lohr NE, Buchtel HA, Silk KR. A preliminary report of short-term cognitive behavioral group therapy for inpatients with personality disorders. J Psychother Pract Res 1996;5:57-71.
77. Barley WD, Buie SE, Peterson EW, et al. Development of an inpatient cognitive-behavioral treatment program for borderline personality disorder. J Personal Disord 1993;7(3):232-240.
78. MacLeod AK, Williams JMG, Linehan MM. New developments in the understanding and. treatment of suicidal behaviour. Behav Psychother 1992;20:193-218.
79. Chowdhury N, Hicks RC, Kreitman N. Evaluation of an after-care service for parasuicide (attempted suicide) patients. Social Psychiatry 1973;8:67-81.
80. Liberman RP, Eckman T. Behavior therapy vs. insight-oriented therapy for repeated suicide attempters. Arch Gen Psychiatry 1981;38: 1126-1130.
81. Salkovskis PM, Atha C, Storer D. Cognitive-behavioral problem solving in the treatment patients who repeatedly attempt suicide. Br J Psychiatry 1990;157:871-876.
82. Munroe-Blum H, Marziali E. Randomized clinical trial of relationship management time-limited group treatment of borderline personality disorder. Hamilton, ON: Ontario Mental Health Foundation, 1987.
83. Turner RM. Case study evaluations of a bio-cognitive-behavioral approach for the treatment of borderline personality disorder. Behav Ther 1989;20:477-489.
84. Waldinger RJ. Intensive psychodynamic therapy with borderline patients: an overview. Am J Psychiatry 1987;144:267-274.
85. Kernberg O, Selzer M, Koenigsberg H, Carr A, Appelbaum A. Psychodynamic psychotherapy of borderline patients. New York: Basic Books, 1989.
86. Frankenberg FR, Zanarini MC. Clozapine treatment of borderline patients: a preliminary study. Compr Psychiatry 1993;34:402-405.
87. Soloff PH. Is there any drug treatment of choice for the borderline patient? Acta Psychiatr Scand 1994;89(Suppl 379):50-55.
88. Norden MJ. Fluoxetine in borderline personality disorder. Prog Neuro-Psychopharmacol Biol Psychiat 1989;13(6):885-893.
89. Cornelius JR, Soloff PH, Perel JM, Ulrich RF. Fluoxetine trial in borderline personality disorder. Psychopharm Bull 1990;26(1):151-154.
90. Links PS, Steiner M, Boiago I, Irwin D. Lithium therapy for borderline patients: preliminary findings. J Personal Disord 1990;4(2):173-181.
91. Cornelius JR, Soloff PH, Perel JM, Ulrich RF. A preliminary trial of fluoxetine in refractory borderline patients. J Clin Psychopharmacol 1991;11(2):116-120.
92. Markovitz PJ, Calabrese JR, Schulz SC, Meltzer HY. Fluoxetine in treatment of borderline and schizotypal personality disorders. Am J Psychiatry 1991;148:1064-1067.
93. Salzman C, Wolfson AN, Schatzberg A, Looper J, Henke R, Albanese M, Schwartz J, Miyawaki E. Effect of fluoxetine on anger in symptomatic volunteers with borderline personality disorder. Ann Clin Psychopharmacol 1995;15(1):23-29.
94. Brinkley R, Beitman BD, Friedel RO. Low-dose neuroleptic regimens in the treatment of borderline patients. Arch Gen Psychiatry 1979;36:319-326.
95. Leone NF. Response of borderline patients to loxapine and chlopromazine. Psychopharmacology 1982;43(4):148-150.
96. Montgomery SA, Montegomery D. Pharmacological prevention of suicidal behaviour. J Affect Disord 1982;4:291-298.
97. Serban G, Siegel S. Response of borderline and schizotypal patients to small doses of thiothixene and haloperidol. Am J Psychiatry 1984;141(11):1455-1458.
98. Goldberg SC, Schulz SC, Schulz PM, et al. Borderline and schizotypal personality disorders treated with low-dose thiothixene vs placebo. Arch Gen Psychiatry 1986;43:680-686.
99. Cowdry RW, Gardner DL. Pharmacotherapy of borderline personality disorder. Arch Gen Psychiatry 1988;45:111-119.
100. Parsons B, Quitkin FM, McGrath PJ, et al. Imipramine, and placebo in borderline patients meeting criteria for atypical depression. Psychopharmacol Bull 1989;25(4):524-534.
101. Soloff PH, George A, Nathan S, et al. Amitriptyline versus haloperidol in borderlines: final outcomes and predictors of response. J Clin Psychopharmacol 1989;9(4):238-246.
102. Teicher MH, Glod CA, Aaronson ST, Gunter PA, Schatzberg AF, Cole JO. Open assessment of the safety and efficacy of thioridaxine in the treatment of patients with borderline personality disorder. Psychopharmacol Bull 1989;25(4):535-549.
103. Cornelius JR, Soloff PH, Perel JM, Ulrich RF. Continuation pharmacotherapy of borderline personality disorder with haloperidol and phenelzine. Am J Psychiatry 1993;150(12):1843-1848.
104. Soloff PH, Cornelius J, George A, Nathan S, Perel JM, Ulrich RF. Efficacy of phenelzine and haloperidol in borderline personality disorder. Arch Gen Psychiatry 1993;30:377-385.
105. Trestman RL, Siever LJ. The pharmacotherapy of borderline personality disorder. CNS Drugs 1994;2(5):347-354.
106. Verkes RJ, Van der Mast RC, Hengeveld MW, Tuyl JP, Zwinderman AH, VanKempen GMJ. Reduction by paroxetine of suicidal behavior in patients with repeated suicide attempts but not major depression. Am J Psychiatry 1998;155:543-547.
107. Montgomery DB, Roberts A, Green M, Bullock T, Baldwin D, Montgomery SA. Lack of efficacy of fluoxetine in recurrent brief depression and suicidal attempts. Eur Arch Psychiatry Clin Neurosci 1994;224:211-215.
108. Mann JJ, Kapur S. The emergence of suicidal ideation and behavior during antidepressant pharmacotherapy. Arch Gen Psychiatry 1991;48:1027-1033.
109. Montgomery SA, Dunner DL, Dunbar GC. Reduction of suicidal thoughts with paroxetine in comparison with reference antidepressants and placebo. Eur Neuropsychopharmacol 1995;5:5-13.
110. Filteau M, Lapierre YD, Bakish D, Blanchard A. Reduction in suicidal ideation with SSRIs: a review of 459 depressed patients. J Psychiatr Neurosci 1993;18(3):114-119.
111. Rubey RN, Johnson MR, Emmanuel N, Lydiard RB. Fluoxetine in the treatment of anger: an open clinical trial. J Clin Psychiatry 1996;57(9):398-401.
112. Coccaro EF, Astill JL, Herbert JL, Schut AG. Fluoxetine treatment of impulsive aggression in DSM-III-R personality disorder patients. J Clin Psychopharmacol 1990;10:373-375.
113. Kavoussi RJ, Liu J, Coccaro EF. An open trial of sertraline in personality disordered patients with impulsive aggression. J Clin Psychiatry 1994;55(4):137-141.
114. Stein DJ, Simeon D, Frenkel M, Islam MN, Hollander E. An open trial of valproate in borderline personality disorder. J Clin Psychiatry 1995;56(11):506-510.
115. Coccaro EF, Siever LJ, Klar HM, et al. Serotonergic studies in patients with affective and personality disorders: correlates with suicidal and impulsive aggressive behavior. Arch Gen Psychiat 1989;46(7):587-599.